Pluripotent stem cells in translation: a Food and Drug Administration-National Institutes of Health collaboration.

Abstract

Recently, the U.S. Food and Drug Administration (FDA), the U.S. National Institutes of Health, and the stem cell research community have collaborated on a series of workshops that address moving pluripotent stem cell therapies into the clinic. The first two workshops in the series focused on preclinical science, and a third, future workshop will focus on… (More)
DOI: 10.5966/sctm.2013-0042

Topics

  • Presentations referencing similar topics